Director, CMC Policy and Advocacy
GSK, District of Columbia, United States
Katharine (Katie) Duncan is a Director of CMC Policy and Advocacy with Global Regulatory Affairs/CMC Excellence. Prior to joining GSK, Katie was a senior pharmaceutical quality assessor with the Office of Pharmaceutical Quality at the US Food and Drug Administration. She previously worked in small molecule drug discovery at a biotechnology company in San Diego, CA. She received her Ph.D. in organic chemistry from the Scripps Research Institute in La Jolla, CA and B.A. from Amherst College in Amherst, Massachusetts.
Global Harmonization in the Diverging Combination Products Space
Thursday, November 13, 2025
10:20 AM - 11:20 AM East Coast USA Time